From April 1st, 2013, to March 31st, 2014, 44 hemodialysis units took part in the surveillance of vascular access–related bloodstream infections (VARBSIs) in hemodialysis (HD) patients, for a combined total of 54,878 patient-periods (Table 1). Participating units reported 157 VARBSIs in 149 patients. Patient-periods involving a fistula accounted for 44.9% of patient-periods. The VARBSI incidence rate was 0.10 cases per 100 patient-periods for patients with an arteriovenous (AV) fistula, 0.22 for patients with a synthetic fistula (graft), 0.38 for patients with a permanent catheter and 6.20 for...
Infection nosocomiale
-
9 mars 2017
-
9 mars 2017
From April 1st, 2013, to March 31st, 2014, 77 healthcare facilities took part on a voluntary basis in the hospital-wide surveillance of bloodstream infections (BSIs), for a combined total of 4,149,763 patient-days (Table 1). Participating facilities reported 2,689 BSIs in 2,495 patients. The total incidence rate was 5.4 cases per 10,000 patient-days. The incidence rate in 2013-2014 was significantly lower compared with the average rate for 2009-2013 in facilities that took part in both surveillance periods. Two teaching and 11 non-teaching facilities that were not included in the 2012-...
-
8 mars 2017
From April 1st, 2013, to March 31st, 2014, 70 intensive care units (ICUs) took part in surveillance of central line–associated bloodstream infections (CLABSIs), for a combined total of 132,376 catheter-days (Table 1). Participating ICUs reported 165 CLABSIs in 149 patients. Incidence rates were 0.65 per 1,000 catheter-days in coronary ICUs, 0.71 in teaching adult ICUs, 0.77 in non-teaching adult ICUs, 2.48 in pediatric ICUs and 4.01 in neonatal ICUs. The incidence rates in 2013-2014 were lower compared to 2009-2013 in teaching and non-teaching adult ICUs as well as in neonatal ICUs while pediatric and...
-
3 mars 2017
From April 1st, 2015, to March 31st, 2016, 45 hemodialysis units took part in the surveillance of vascular access–related bloodstream infections (VARBSIs) in hemodialysis (HD) patients, for a combined total of 54,717 patient-periods (Table 1), slightly less than the preceding year. Participating units reported 136 VARBSIs in 129 patients. Patient-periods involving a fistula account for 41.0% of patient-periods. The 2015-2016 VARBSI incidence rates are 0.06 cases per 100 patient-periods for patients with an arteriovenous (AV) fistula, 0.32 for patients with a synthetic fistula (graft), 0.33 for...
-
3 mars 2017
From April 1st, 2015, to March 31st, 2016, 66 intensive care units (ICUs) took part in surveillance of central line–associated bloodstream infections (CLABSIs), for a combined total of 128,035 catheter-days (Table 1). Participating ICUs reported 150 CLABSIs in 139 patients. Incidence rates are 0.70 per 1,000 catheter-days in teaching adult ICUs, 0.42 in non-teaching adult ICUs, 1.95 in pediatric ICUs and 4.15 in neonatal ICUs (including cases with a mucosal barrier injury). No case is observed in coronary ICUs. Compared to 2014-2015, a coronary ICU and a teaching ICU stopped participating, while a...
-
3 mars 2017
From April 1st, 2015, to March 31st, 2016, 87 healthcare facilities took part in the hospital-wide surveillance of bloodstream infections (BSIs), for a combined total of 4,770,053 patient-days (Table 1). Participating facilities reported 3,173 BSIs in 2,948 patients. The total 2015-2016 incidence rate is 5.45 cases per 10,000 patient-days for all facilities participating in 2015-2016, and it is 5.35 for facilities that participated in 2015-2016 as well as in at least one year between 2011-2012 and 2014-2015. No non-catheter-related primary bloodstream infection (non-CRBSI) with a...
-
1 mars 2017
From April 1, 2015, to March 31, 2016, 73 healthcare facilities took part in the surveillance of carbapenemase-producing Gram negative bacilli (CPGNB) infections, for a total of 3,749,277 patient days (Table 1). In total, four CPGNB infections were reported among patients who acquired their strain during a current or previous hospital stay in the reporting facility (categories 1a and 1b). The incidence rate of healthcare-associated CPGNB infection (cat. 1a and 1b) was 0.011 per 10,000 patient days. The acquisition rate of healthcare-associated CPGNB colonization (cat. 1a and 1b) was 0.197 per 10,000 patient days. Two...
-
28 février 2017
From April 1, 2015, to March 31, 2016, 89 healthcare facilities took part in the surveillance of healthcare-associated vancomycin-resistant enterococci (VRE) infections, for a combined total of 4,833,086 patient days (Table 1). In total, 78 VRE infections were reported among patients who contracted strain during a current or previous hospital stay in the reporting facility (categories 1a and 1b). The incidence rate of healthcare-associated VRE infection (cat. 1a and 1b) was 0.16 per 10,000 patient days. This incidence rate was stable since 2014-2015. The acquisition rate of healthcare-associated VRE colonization (cat. 1a...
-
28 février 2017
From April 1, 2015, to March 31, 2016, 89 healthcare facilities participated in the surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections, for a combined total of 4,851,752 inpatient days (Table 1). Together, these facilities reported 65 cases of healthcare-associated MRSA bloodstream infections (HA-MRSA-BSI). The incidence rate was 0.13 per 10,000 patient-days. This incidence rate of HA-MRSA-BSI has declined over the past five years. The proportion of methicillin resistance in healthcare-associated S. aureus bloodstream infections was 12.6%. Data was...
-
16 décembre 2016
En 2010, le Comité sur les infections nosocomiales du Québec (CINQ) publiait des lignes directrices pour la prévention et le contrôle de la transmission des entérobactéries productrices de carbapénémases, puis plus récemment en 2015, les mesures pour la prévention et le contrôle de la transmission des bacilles Gram négatif multirésistants (BGNMR) en milieux de soins aigus.
L’application de mesures de prévention et contrôle des infections (PCI) dans les milieux d’hébergement et de soins de longue durée (CHSLD) doit être adaptée aux caractéristiques propres à ces milieux, ainsi qu’à la clientèle qui y est hébergée. L’objectif de ce document est de présenter aux intervenants en PCI des centres d’hébergement et de soins de longue durée (CHSLD) et aux cliniciens qui y...
Pages
